Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glyn Lewis

Showing results (471-480 of 494) with videos related to

Pageof 50
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 24, 2018
Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studiesChiara Fabbri, Katherine E Tansey, Roy H Perlis, et al.
International Psychogeriatrics|October 22, 2016
Prevalence of anxiety disorders in community dwelling older adults in Hong KongAda Wai Tung Fung, Wai-Chi Chan, Corine Sau-Man Wong, et al.
The Lancet Regional Health. Europe|February 16, 2024
The impact of psychiatric comorbidity on Parkinson's disease outcomes: a systematic review and meta-analysisElla Burchill, Cameron James Watson, Jack B Fanshawe, et al.
Trials|October 6, 2023
Randomised controlled trial of the Community Navigator programme to reduce loneliness and depression for adults with treatment-resistant depression in secondary community mental health services: trial protocolTheodora Stefanidou, Gareth Ambler, Gergely Bartl, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputationDanyang Li, Oliver Pain, Chiara Fabbri, et al.
Health Technology Assessment (Winchester, England)|March 29, 2024
Patient-reported outcome measures for monitoring primary care patients with depression: the PROMDEP cluster RCT and economic evaluationTony Kendrick, Christopher Dowrick, Glyn Lewis, et al.
Plos Medicine|October 24, 2012
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysisKatherine E Tansey, Michel Guipponi, Nader Perroud, et al.
Translational Psychiatry|July 18, 2024
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysisDanyang Li, Oliver Pain, Chiara Fabbri, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 26, 2024
Depression follow-up monitoring with the PHQ-9: an open cluster-randomised controlled trialTony Kendrick, Christopher Dowrick, Glyn Lewis, et al.
BMJ Open|March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocolLumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Pageof 50

Showing results (471-480 of 494) with videos related to

Sort By:
Pageof 50
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 24, 2018
Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studiesChiara Fabbri, Katherine E Tansey, Roy H Perlis, et al.
International Psychogeriatrics|October 22, 2016
Prevalence of anxiety disorders in community dwelling older adults in Hong KongAda Wai Tung Fung, Wai-Chi Chan, Corine Sau-Man Wong, et al.
The Lancet Regional Health. Europe|February 16, 2024
The impact of psychiatric comorbidity on Parkinson's disease outcomes: a systematic review and meta-analysisElla Burchill, Cameron James Watson, Jack B Fanshawe, et al.
Trials|October 6, 2023
Randomised controlled trial of the Community Navigator programme to reduce loneliness and depression for adults with treatment-resistant depression in secondary community mental health services: trial protocolTheodora Stefanidou, Gareth Ambler, Gergely Bartl, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputationDanyang Li, Oliver Pain, Chiara Fabbri, et al.
Health Technology Assessment (Winchester, England)|March 29, 2024
Patient-reported outcome measures for monitoring primary care patients with depression: the PROMDEP cluster RCT and economic evaluationTony Kendrick, Christopher Dowrick, Glyn Lewis, et al.
Plos Medicine|October 24, 2012
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysisKatherine E Tansey, Michel Guipponi, Nader Perroud, et al.
Translational Psychiatry|July 18, 2024
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysisDanyang Li, Oliver Pain, Chiara Fabbri, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 26, 2024
Depression follow-up monitoring with the PHQ-9: an open cluster-randomised controlled trialTony Kendrick, Christopher Dowrick, Glyn Lewis, et al.
BMJ Open|March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocolLumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Pageof 50